Mohandass Palanisamy1,2, Khanna David1, Manigandan Durai3, Narendra Bhalla2, Abhishek Puri2. 1. Department of Physics, School of Engineering and Technology, Karunya Institute of Technology and Sciences, Coimbatore, Tamilnadu, India. 2. Department of Radiation Oncology, Fortis Cancer Institute, Fortis Hospital, Mohali, Punjab, India. 3. Department of Radiotherapy, Medanta The Medicity Hospital, Gurgaon, Haryana, India.
Abstract
AIM: To study the dosimetric impact of statistical uncertainty (SU) per plan on Monte Carlo (MC) calculation in Monaco™ treatment planning system (TPS) during volumetric modulated arc therapy (VMAT) for three different clinical cases. BACKGROUND: During MC calculation SU is an important factor to decide dose calculation accuracy and calculation time. It is necessary to evaluate optimal acceptance of SU for quality plan with reduced calculation time. MATERIALS AND METHODS: Three different clinical cases as the lung, larynx, and prostate treated using VMAT technique were chosen. Plans were generated with Monaco™ V5.11 TPS with 2% statistical uncertainty. By keeping all other parameters constant, plans were recalculated by varying SU, 0.5%, 1%, 2%, 3%, 4%, and 5%. For plan evaluation, conformity index (CI), homogeneity index (HI), dose coverage to PTV, organ at risk (OAR) dose, normal tissue receiving dose ≥5 Gy and ≥10 Gy, integral dose (NTID), calculation time, gamma pass rate, calculation reproducibility and energy dependency were analyzed. RESULTS: CI and HI improve as SU increases from 0.5% to 5%. No significant dose difference was observed in dose coverage to PTV, OAR doses, normal tissue receiving dose ≥5 Gy and ≥10 Gy and NTID. Increase of SU showed decrease in calculation time, gamma pass rate and increase in PTV max dose. No dose difference was seen in calculation reproducibility and dependent on energy. CONCLUSION: For VMAT plans, SU can be accepted from 1% to 3% per plan with reduced calculation time without compromising plan quality and deliverability by accepting variations in point dose within the target.
AIM: To study the dosimetric impact of statistical uncertainty (SU) per plan on Monte Carlo (MC) calculation in Monaco™ treatment planning system (TPS) during volumetric modulated arc therapy (VMAT) for three different clinical cases. BACKGROUND: During MC calculation SU is an important factor to decide dose calculation accuracy and calculation time. It is necessary to evaluate optimal acceptance of SU for quality plan with reduced calculation time. MATERIALS AND METHODS: Three different clinical cases as the lung, larynx, and prostate treated using VMAT technique were chosen. Plans were generated with Monaco™ V5.11 TPS with 2% statistical uncertainty. By keeping all other parameters constant, plans were recalculated by varying SU, 0.5%, 1%, 2%, 3%, 4%, and 5%. For plan evaluation, conformity index (CI), homogeneity index (HI), dose coverage to PTV, organ at risk (OAR) dose, normal tissue receiving dose ≥5 Gy and ≥10 Gy, integral dose (NTID), calculation time, gamma pass rate, calculation reproducibility and energy dependency were analyzed. RESULTS: CI and HI improve as SU increases from 0.5% to 5%. No significant dose difference was observed in dose coverage to PTV, OAR doses, normal tissue receiving dose ≥5 Gy and ≥10 Gy and NTID. Increase of SU showed decrease in calculation time, gamma pass rate and increase in PTV max dose. No dose difference was seen in calculation reproducibility and dependent on energy. CONCLUSION: For VMAT plans, SU can be accepted from 1% to 3% per plan with reduced calculation time without compromising plan quality and deliverability by accepting variations in point dose within the target.
Entities:
Keywords:
Larynx; Lung; Monte Carlo dose algorithm; Prostate; Statistical uncertainty; VMAT
Authors: Hidefumi Aoyama; David Clark Westerly; Thomas Rockwell Mackie; Gustavo H Olivera; Søren M Bentzen; Rakesh R Patel; Hazim Jaradat; Wolfgang A Tome; Mark A Ritter; Minesh P Mehta Journal: Int J Radiat Oncol Biol Phys Date: 2006-03-01 Impact factor: 7.038
Authors: C M Ma; T Pawlicki; S B Jiang; J S Li; J Deng; E Mok; A Kapur; L Xing; L Ma; A L Boyer Journal: Phys Med Biol Date: 2000-09 Impact factor: 3.609
Authors: Vladimir Feygelman; Kujtim Latifi; Mark Bowers; Kevin Greco; Eduardo G Moros; Max Isacson; Agnes Angerud; Jimmy Caudell Journal: J Appl Clin Med Phys Date: 2022-02-25 Impact factor: 2.243